Annals of Hematology

, Volume 64, Supplement 1, pp A125–A127 | Cite as

Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stroma

  • M. J. Reddehase
  • L. Dreher-Stumpp
  • P. Angele
  • M. Balthesen
  • M. Šuša


Cytomegalovirus (CMV) recurrence from latency is a major risk factor in bone marrow transplantation (BMT). Owing to the immunodepletive treatment, ablation of the immune control of latent CMV is responsible for recurrence and cytopathogenic spread of the virus in vital tissues. There is increasing evidence for reconstituting bone marrow being itself a target tissue of CMV. By inhibiting post-transplantation hematopoiesis, CMV is causal for maintenance of the immunocompromised state, which leads to a prolonged phase of persistent virus replication. Based on results in a murine model of BMT and concurrent CMV infection, we discuss possible mechanisms of CMV-mediated bone marrow graft failure. It is concluded that an irremediable damage of bone marrow stroma by CMV is responsible for a reduced rate of regeneration of the marrow-repopulating, pluripotent stem cell.

Key words

Cytomegalovirus Bone marrow transplantation Bone marrow stroma Hematopoietic stem cells Steel syndrome 


  1. 1.
    Apperley JF, Dowding C, Hibbin J, Buiter J, Matutes E, Sissons PJ, Gordon M, Goldman JM (1989) The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp Hematol 17: 38–45Google Scholar
  2. 2.
    Busch FW, Mutter W, Koszinowski UH, Reddehase MJ (1991) Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone marrow stroma. J Virol 65: 981–984Google Scholar
  3. 3.
    Forman SJ (1991) Bone marrow transplantation. Transplant Proc 23 [Suppl 3]: 110–114Google Scholar
  4. 4.
    Ho M (1991) Observations from transplantation contributing to the understanding of pathogenesis of CMV infection. Transplant Proc 23 [Suppl 3]: 104–109Google Scholar
  5. 5.
    Jones RJ, Wagner JE, Celano P, Zicha MS, Sharkis SJ (1990) Separation of pluripotent hematopoietic stem cells from spleen colony-forming cells. Nature 347: 188–189Google Scholar
  6. 6.
    Koszinowski UH, Del Val M, Reddehase MJ (1990) Cellular and molecular basis of the protective immune response to cytomegalovirus infection. Curr Top Microbiol Immunol 154: 189–220Google Scholar
  7. 7.
    Meyers JD, Flournoy N, Thomas ED (1986) Risk factors for cytomegalovirus infection after human bone marrow transplantation. J Infect Dis 153: 478–488Google Scholar
  8. 8.
    Mutter W, Reddehase MJ, Busch FW, Bühring H-J, Koszinowski UH (1988) Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J Exp Med 167: 1645–1658Google Scholar
  9. 9.
    Paulin T, Ringden O, Lonnquist B (1985) Faster immunological recovery after bone marrow transplantation in patients without cytomegalovirus infection. Transplantation 39: 377–384Google Scholar
  10. 10.
    Philipps RA (1985) Comparison of different assays for multipotent hematopoietic stem cells. In: Ford RJ, Maizel AL (eds) Mediators in cell growth and differentiation. Raven, New York, pp 135–145Google Scholar
  11. 11.
    Quesenberry PJ (1989) Stromal cells in long-term bone marrow cultures. In: Tavassoli M (ed) Handbook of the hemopoietic microenvironment. Humana, Clifton, NJ, pp 253–285Google Scholar
  12. 12.
    Reddehase MJ (1991) Bone marrow dysfunction in irradiated, cytomegalovirus-infected mice. Transplant Proc 23 [Suppl 3]: 8–11Google Scholar
  13. 13.
    Simmons P, Kaushansky K, Torok-Storb B (1990) Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci USA 87: 1386–1390Google Scholar
  14. 14.
    Witte ON (1990) Steel locus defines new multipotent growth factor. Cell 63: 5–6Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • M. J. Reddehase
    • 1
  • L. Dreher-Stumpp
    • 1
  • P. Angele
    • 1
  • M. Balthesen
    • 1
  • M. Šuša
    • 1
  1. 1.Department of Virology, Institute for MicrobiologyUniversity of UlmUlmGermany

Personalised recommendations